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Background: Chronic kidney disease screening using estimated glomerular filtration rate (eGFR) reporting is
standard in many regions. With its implementation, many centres have had higher referral rates and increased wait
times to see nephrologists.
Objective: Manitoba began eGFR reporting in October 2010. We measured the effect of eGFR reporting on referral
rates, wait times, and appropriateness of referrals after an educational intervention.
Design: An interrupted time series design was used.
Setting: This study took place in Manitoba, Canada.
Patients: All referrals to the Manitoba Renal Program in the period prior to eGFR reporting between April 1, 2010
and September 30, 2010 were compared with a post period between January 1, 2011 and June 30, 2011.
Measurements: Data on demographics, co-morbidities, referral numbers and wait times were compared between
periods. Appropriateness of consults was also measured after eGFR implementation.
Methods: Prior to eGFR reporting, primary care physicians underwent educational interventions on eGFR
interpretation and referral guidelines. Referral rates and wait times were compared between periods using
generalized linear models. Chart audits of a random sample of 232 patients in the pre period and 239 patients in
the post period were performed.
Results: The pre and post eGFR reporting referral rate was 116 and 152 referrals/month, respectively. Average wait
times in the pre and post eGFR reporting was 113 and 115 days, respectively. Non-urgent referral wait times increased
by 40 days immediately post reporting, while urgent median referral wait times had a more gradual increase. Despite
our intervention, inappropriate consultations post eGFR reporting was 495/790 (62.7%).
Limitations: Our study did not measure the intervention’s success on primary care providers, which may have affected
our appropriateness data. Our time series design was not powered to find a statistically significant difference in referral
numbers. Residual confounding of our results was possible given the retrospective nature of our study.
(Continued on next page)* Correspondence: pkomenda@sbgh.mb.ca
2Department of Medicine, Section of Nephrology, University of Manitoba,
Winnipeg MB, Canada
3Seven Oaks General Hospital Renal Program, 2300 Mcphillips Street, 2PD12,
Winnipeg R2V 3M3, MB, Canada
Full list of author information is available at the end of the article
© 2014 Hingwala et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Hingwala et al. Canadian Journal of Kidney Health and Disease 2014, 1:9 Page 2 of 8
http://www.cjkhd.org/content/1/1/9(Continued from previous page)
Conclusion: Despite our educational intervention, the inappropriate referrals remained high, and wait times increased.
Other systemic interventions should be considered to attenuate the potential negative effects of eGFR reporting and
ensure timely access for patients needing specialist consultation.
Keywords: eGFR, Quality improvement, ReferralBackground
Chronic Kidney Disease (CKD) is a major public health
problem associated with a significant burden of morbidity,
mortality and increased health care costs. Early detection
of CKD may help mitigate poor outcomes and reduce the
high costs associated with renal replacement therapies.
Accurate assessment of kidney function, also known as
glomerular filtration rate (GFR), is an important part of
CKD screening as it facilitates earlier diagnosis, staging,
proper dosing of medications, and ultimately planning for
renal replacement therapy [1]. By earlier referral to neph-
rology teams, a potential opportunity to attenuate CKD
progression and manage complications is created [2]. GFR
can be estimated (eGFR) in numerous ways, with one of
the most common methods being the MDRD equation
using variables of serum creatinine, age, sex, and race. Rou-
tine reporting of eGFR using the MDRD or the CKD-EPI
study equation is now common in many countries and in
most Canadian provinces, despite being validated only in
certain populations [3].
The widespread use of automatic eGFR reporting has
been shown to allow better detection of CKD in the general
population [4-6], but has been associated with increased re-
ferrals to nephrologists and subsequently longer wait times
[6-9]. Automatic eGFR reporting has also increased the
number of inappropriate referrals to nephrologists [4]. Strat-
egies to educate primary care clinicians in order to increase
the proportion of appropriate referrals, including how to in-
terpret eGFR’s and when to refer patients to nephrologists
have been tried, but have had limited success [5].
The purpose of this study was to evaluate a multi-
faceted public health campaign in Manitoba to improve
the appropriateness of nephrology referrals after the im-
plementation of province wide automatic eGFR reporting.
Methods
Population studied
Manitoba is a province located in central Canada, with
the population of 1.27 million people with the second
highest incidence and prevalence of end stage renal dis-
ease (ESRD) in Canada [10]. Over half of the population
lives in the province’s capital city Winnipeg, with the re-
mainder spread across an area of 649,950 km [2,11].
Manitoba is culturally diverse with almost 10% of the
population a member of a visible minority, and 14% abo-
riginal [12]. In Winnipeg, there are three dialysis centres,which together see all nephrology referrals within the prov-
ince to the Manitoba Renal Program (MRP). Referrals are
currently sent to a specific site for either a specific physician
or into a general pool to distribute among physicians at the
site. Once a referral is received, they are triaged as urgent
or non-urgent by the individual nephrologist.Collection and reporting
The University of Manitoba Regional Ethics Board ap-
proved this study prior to its commencement. Manitoba
implemented routine eGFR reporting in October of 2010.
All new referrals between April 1, 2010 and September 30,
2010 were considered in this study as a sample of the pre
implementation consults received to the MRP. A 3-month
lag period was then observed as a transition period to the
new reporting system. The post implementation sample
was taken from January 1, 2011 to June 30, 2011. Thirteen
weeks were chosen at random in the pre and post period
representing a total of 232 patients from all three centres
in the pre period and 239 patients in the post period. This
sample of patients underwent complete chart reviews for
demographics, co-morbidities, referral reasons, data sent
with referral and wait times between referral and date seen
by a nephrologist. An observed lag time of 2 years was
given for primary care physicians to review and begin util-
izing the MRP referral pathways before the appropriate-
ness data was collected from a random population.
The province contains laboratory services that are both
provincially and privately run. Those provincially run labs
began reporting on October 25, 2010. Private labs started
reporting December 31, 2010. eGFR was only reported for
outpatients (ie. not in ER and inpatients). Prior to report-
ing, each lab was provided with IDMS traceable reference
standards in order to ensure accuracy of measurement and
calibration. For all patients with eGFR values greater than
60, values were standardized to be reported as “eGFR > 60”
without displaying the eGFR. For those who had eGFR less
than 60, the value was given along with the creatinine, with
a laboratory prompt indicating that their patient may have
CKD and referring them to a website containing the MRP
referral guidelines and pathways (www.kidneyhealth.ca).
EGFR was not calculated in the pre period, as it previously
has been shown that without standardization to IDMS-
traceable creatinine in all labs, can lead to error in meas-
urement of eGFR [13].
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A referral was deemed appropriate if any one of the fol-
lowing were present: 1) eGFR at time of referral of less
than 30 ml/min 2) urine protein:creatinine ratio or urine
albumin:creatinine ratio greater than 200 mg/mmol 3)
24 hour urine collection with greater than 2 grams protein
4) a rapid decline in eGFR of more than 10% per year or
20% in a shorter interval 5) suspected glomerulonephritis
6) structural kidney disease including renal cysts 7) special
reason given by primary care physician including diabetic
nephropathy, difficult to control hypertension, electrolyte
abnormalities, hematuria NYD, renal stones, abnormal
monoclonal deposition disease (ex. amyloid, light chain,
myeloma). These criteria were clearly indicated on the re-
ferral forms at www.kidneyhealth.ca (an educational web-
site maintained by the Manitoba Renal Program).
Educational intervention
Three months prior to the eGFR reporting, the project lead
nephrologist met with health administrators, lab techni-
cians, and family physicians. Referral pathways were created
in collaboration between a group of seven nephrologists
and seven family physicians over several working group ses-
sions supervised and facilitated by Manitoba Health. Each
primary care physician in the province was then mailed an
education package, including pathways of when to refer to
nephrologists, and explanations of treatment and interven-
tion pathways, and a poster was provided explaining the
stages of CKD with coinciding therapeutic goals. Several di-
dactic lectures took place in this period in both rural and
urban sites, with lectures available by tele-link to over 8
sites in an attempt to promote and facilitate education on
eGFR. In addition, a new website was launched with mate-
rials explaining how to interpret eGFR and proteinuria,
chronic kidney disease stages and management, and referral
pathways. Additional materials were supplemented using
YouTube© videos, webcasts, live presentations, mailing
lists, pamphlets, posters, and mailing an educational pack-
age to all primary care physicians and nurse practitioners in
the province. When a referral was felt to be appropriate by
a primary care clinician, they were instructed to complete a
standardized referral form made available in the mailing
and on the website. This form contained categories of
emergent (consults to be seen within 24 hours), urgent
(seen within 4 weeks), or elective (to be seen within
6 months) to be used in concert with the referral pathways.
Emergent referrals required direct telephone contact with
nephrologists who were available 24/7/365 to discuss the
case; urgent referrals reasons included hematuria, suspected
GN, non diabetic proteinuria, stable GFR < 15 without dia-
lysis indications, GFR 15–30, or 30–59.5 with a decline of
greater than 10% per year. Elective referral reasons were
GFR less than 60, with significant proteinuria of an ACR or
PCR more than 200 mg/mmol, or hematuria suspectingGN, or other reason that fulfill the above criteria (to be spe-
cified to clinician). Also requested with referrals were a
medical history and additional investigations of urinalysis,
proteinuria/albuminuria quantification, two eGFR measure-
ments, CBC, electrolytes, urea, creatinine, albumin, serum
and urine protein electrophoresis where appropriate, and
renal ultrasound.
All materials presented to primary care physicians, in-
cluding the referral pathway, are available online at http://
www.kidneyhealth.ca/wp/healthcare-professionals. 6months
after the eGFR reporting, the information package was
again mailed to all primary care clinicians.Data analysis
The average wait time and number of consults were com-
pared between the pre- and post-eGFR reporting period
using a general linear model. Each model contained a vari-
able for reporting month, an indicator variable represent-
ing the post-eGFR period, and an interaction term
between the reporting month and post-eGFR indicator.
The immediate change in number of consults or average
wait time resulting from eGFR reporting was represented
by the coefficient of the post-eGFR indicator variable. The
change in slope following eGFR reporting was represented
by the coefficient of the interaction term between report-
ing month and the eGFR indicator variable. A three-
month period immediately following implementation of
eGFR reporting was excluded from the final analysis to
allow for an appropriate transition period. Demographic
comparisons were made between the pre- and post-eGFR
reporting period. Continuous variables are expressed as
mean and standard deviation and compared between both
groups using independent t-tests. Categorical variables are
expressed frequencies and percentages and compared be-
tween both groups using a chi-square test. All statistical
analysis was performed using SAS version 9.2 (Cary, NC)
for Microsoft Windows. Visual representations of these
models (Figures 1, 2, 3 and 4) were developed using Micro-
soft Excel 2010 (Seattle, WA).Results
The patient demographics pre and post implementation
of automatic eGFR reporting are shown in Table 1. The
majority of patients came from Site 1, which is also the
largest referral site in the province. Although not signifi-
cantly different, the post implementation group did have
an older mean age of 60.5. There was a similar distribu-
tion of males and females between periods. Comorbid
data showed similar rates of patients with diabetes or
hypertension in the pre and post periods. The group in
the post period did have a larger proportion using renin-
angiotensin blocking medications.
Figure 1 Total new referrals by pre and post eGFR consult periods.
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The number of referrals received in the period before
automatic eGFR reporting was about 116/month, with
109 referrals/month at the end of the pre-eGFR reporting
period. In the post period, that number increased to 152
referrals/month, with 136 referrals/month at the end of
this period (Figure 1). Based on our random sample of all
referrals, the majority of the referrals in both periods were
non-urgent (Figure 2). In the pre-eGFR period, nephrolo-
gists had a total of 672 new consult visits. In the post-
eGFR period, nephrologists had 871 new consult visits.
There were similar equivalent full time nephrologists
working in both periods.
Wait times
The average wait time before the eGFR period was
113 days, increasing to 115 days post implementationFigure 2 Total new referrals by pre and post eGFR consult periods - s(Figure 3). However, the wait time’s trend continued to rise
over time in the post period. Examining only non-urgent
referrals, the wait time increased by 40 days immediately
after GFR reporting (p < 0.01) (Figure 4). For urgent refer-
rals, the wait time did not increase initially, but as time
went on, and the overall number of referrals increased, the
wait time for urgent referrals also began to rise. By the end
of the six-month post-GFR period, the median wait time
was 150 days for urgent referrals compared to 70 days at
the end of the pre-GFR period.
Appropriateness of referrals
In the period of January 1, 2012 to May 31, 2013, 790 ran-
dom referrals were audited for appropriateness. 495/790
(62.7%) of the referrals were not considered appropriate
for nephrology using our criteria. Of the appropriate refer-
rals, 186 (23.6%) had eGFR less than 30 ml/min, 25 (3.2%)tratified by urgency.
Figure 3 Wait times by pre and post eGFR consult periods. *No statistically significant difference in slope or intercept (p=0.08 & p=0.77);
Intercept is defined as March 2010 for Pre GFR line of best fit, and December 2010 for Post GFR line of best fit. **Average wait time was
calculated by taking weighted average weight time from four locations.
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and significant proteinuria, and 63 (8%) were referred for
one of the specific reasons listed above. Of the inappropri-
ate referrals, 386/495 (78%) stated referral reasons as a de-
creased eGFR. In the post period, the average patient
eGFR at referral time was 40.3. The mean creatinine pro-
vided at time of referral in the pre-period was 172.3 umol/
L, while the mean creatinine at referral time in the post
period was lower at 139.8 umol/L.
Discussion
The implementation of automatic eGFR reporting in
Manitoba led to an increased number of nephrology refer-
rals in the province. This resulted in a modest increased
wait time for non-urgent referrals, and a concerning trend
for increasing wait times in urgent referrals. Our findingsFigure 4 Wait times by pre and post eGFR consult periods - stratified
Pre and Post GFR Periods for NS/Non Urgent Group (p<0.001). **Statisticall
Semi-Urgent/Urgent Group (p<0.001).parallel those of other centers, where eGFR led to more
referrals, especially with older patients [4,7,8]. The propor-
tion of inappropriate consultations remained high at
62.7% after our multifaceted educational intervention for
primary care practitioners.
To our knowledge, only one previous study by Phillips
et al. has simultaneously studied the combination of neph-
rology referrals, appropriateness of consultations, and wait
times in the context of automatic eGFR reporting [14]. This
study was conducted in the United Kingdom, where a sig-
nificant proportion of income for primary care physicians
are linked to certain quality targets in CKD management.
After eGFR reporting began, a similar rise in nephrology
consultations was reported. Shortly after, a patient referral
pathway to guide primary care physicians for appropriate-
ness of referral was disseminated, and found to improve theby urgency. *Statisticallu significant intercept differences between
u significant slope differences between Pre and Post GFR Periods for
Table 1 Baseline patient demographics
Variable Pre GFR consult Post GFR consult P-value
(N=232) (N=239)
Age 57.3 15.8 60.5 15.4 0.0532
Referral site 0.0523
HSC 99 42.7% 139 58.2%
SBGH 49 21.1% 57 23.9%
SOGH 55 23.7% 43 18.0%
Not specified 29 12.5% 0 0.0%
Gender 0.6742
Male 127 54.7% 136 56.9%
Female 104 44.8% 103 43.1%
Not specified 1 0.4% 0 0.0%
Diabetes 0.973
No 125 53.8% 122 51.1%
Type I 8 3.5% 8 3.4%
Type II 97 41.8% 99 41.4%
Not Specified 2 0.9% 10 4.2%
Hypertension 0.1062
No 83 35.8% 68 28.5%
Yes 147 63.4% 166 69.5%
Not specified 2 0.9% 5 2.1%
ACE/ARB inhibitors 0.0011
No 134 57.8% 91 38.1%
ACE only 56 24.1% 75 31.4%
ARB only 34 14.7% 52 21.8%
Both 7 3.0% 12 5.0%
Not specified 1 0.4% 9 3.8%
Categorical variables are expressed as N (%).
Numerical variables are expressed as Mean (Standard Deviation).
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system in that it does not tie financial reimbursement to
quality targets in primary care, and therefore a similar strat-
egy may not be as effective in attenuating inappropriate
consult rates. We therefore attempted a more robust edu-
cational strategy including an analogous referral pathway as
the Phillips et al. study.
Automatic eGFR reporting has led to more referrals in
many studies, which in many cases has allowed the cap-
ture of more patients with CKD [15,16]. Earlier identifica-
tion of these patients by primary care clinicians allows for
treatment to attenuate CKD progression to ESRD through
interventions such as tight blood pressure control, renin-
angiotensin system inhibitors, and consultation with a
nephrologist [17-20]. The STAARTstudy demonstrated that
patients who have follow up for greater than one year by a
nephrologist are more likely to have optimal dialysis starts
with pre-emptively created fistulas, start on peritoneal dialy-
sis, begin dialysis as elective outpatients, and have a lowermortality rates. However, the increased referral rates that
have been seen with eGFR reporting have not paralleled a
significant change in “appropriate nephrology consultations”
or lessened the progression to end stage renal disease. This
is likely due to the fact that the majority of the new referrals
are at low risk of CKD progression to ESRD [4,5,9].
Improving front line providers knowledge and aware-
ness of CKD is an essential element for effective, “appro-
priate”, risk based triage of referrals to nephrology [21].
Primary care clinicians have indicated a need for more
education in areas of eGFR interpretation, clinical utility,
and methods of conveying its meaning to patients [16,22].
They have also expressed that they would like feedback on
their current CKD care practices, when to refer to a special-
ist, established roles in clinical care before and after nephrol-
ogy referrals, and regular updates on current guidelines of
best practices [16,23]. The need to provide support in these
areas is reinforced by multiple studies, which have illustrated
disparities in primary care clinicians CKD knowledge trans-
lation, recognition of CKD risk factors [24], interpretation of
creatinine and eGFR measurements, diagnostic evaluation
for CKD, and utilization of current management guidelines
[25]. Our program employed a comprehensive public health
strategy to encourage proper utilization of the eGFR tool by
deriving referral pathways in collaboration between nephrol-
ogists and primary care physicians and using mass mail outs,
didactic presentations, web-based videos, and dedicated
web-based resources to disseminate knowledge on appropri-
ate referrals. Despite these efforts, the numbers of inappro-
priate referrals remained high and wait times increased.
There are several clinical, research and public health
implications to our findings. Clinical practice guidelines
have been a popular strategy used to address gaps in CKD
recognition and advise when to prompt a nephrology re-
ferral. Similar to our study however, practice guidelines
have not been an effective solution to bridge these incon-
sistencies. Previous studies have described reasons why
guidelines are ineffective in primary care, including pro-
vider lack of awareness and familiarity with guidelines, dis-
agreement with recommendations, lack of confidence
with self-efficacy or time to carry out recommendations,
apprehension to change previous practices, and absence of
external pressures to change practices [26]. In the case of
nephrology, this problem is compounded by regional vari-
ation of guidelines [27,28], the increasingly complexity of
making a CKD diagnosis, the development of new equa-
tions such as CKD-EPI and cystatin C, and the incorpor-
ation of proteinuria with staging [29].
Recognition of high risk patients by simpler methods of
interpretation, such as printed reports with statements
reminding appropriate referral guidelines, or the KDIGO
heatmap [30,31], could incorporate these new variables into
a more concise model that would be easier to apply in pri-
mary care. Computer decision support systems [32,33] such
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assistants [34] are potential promising solutions in increasing
physician awareness and detection of CKD, decreasing dupli-
cation of tests, ease comparisons with prior results, and pro-
viding alerts when labs results return. It also has the ability
to advise drug-dosing, interpretation of results, and provide
referral suggestions. One additional benefit of computer
support systems for patients, is that they can review their in-
dividual results from their own computers, potentially im-
proving their interest and self-management of their own
diseases [25]. A potential effective approach to improve prac-
tice patterns would be to audit current performances of
primary care providers, then convey benchmarks or compar-
isons of certain indicators to them while reinforcing indica-
tions for an appropriate referral to nephrology [33]. This
type of feedback on current performance has been shown in
numerous quality improvement initiatives to improve CKD
awareness and management, especially when combined with
key opinion leaders messages’ [31].
A more robust and perhaps more effective strategy may
be to intervene on the process of referral intake. Central-
ized, standard referral processes allows for a single triage
area to receive, process, screen for appropriateness of the
referral and completeness of the consultation, and to
evenly distribute referrals. More urgent consults could be
better triaged, completeness of referral information should
be ensured to prevent secondary delays, and wait lists can
be balanced for each nephrologist. Subspecialty nephrol-
ogy clinics, such as glomerulonephritis, hypertension,
CKD with pregnancy, or genetic disease clinics, can have
referrals directed toward them more efficiently as well in a
triage based system. Utilization of risk prediction equa-
tions [35] can also help prioritize the urgency and neces-
sity for low risk patients to be seen by nephrology.
This study has several strengths, including a random
sample of groups in the pre and post eGFR implementa-
tion periods for group comparisons of demographics and
wait times. The MRP receives all nephrology referrals in
the province allowing for virtually complete data capture
of referred patients. Although our educational interven-
tion was multi-faceted, one limitation of our study was
that we did not measure how well primary care providers
reviewed or grasped the content, which may have affected
our appropriateness data. Another limitation in our time
series design is that we provide 6 data points in the pre
and post periods for number of referrals, which yielded a
trend, but may have been statistically significant had we
had increased power. We did not report race with our
demographics, as this information was not available to us.
However, Manitoba has a small African American popula-
tion of less than 1.4% [36], so the calculated mean eGFR
was unlikely to be largely influenced by this missing infor-
mation. In addition, the retrospective nature of our study
did not allow us to measure all key statistics that couldinfluence our outcomes, making residual confounding of
our results a possibility.
Conclusions
In conclusion, EGFR implementation has shown to be a
useful tool in CKD screening, but with it has come chal-
lenges of increase nephrology referrals and longer wait
times. In Manitoba, despite our significant efforts at a ro-
bust knowledge translation initiative we also encountered
similar setbacks. A higher yield to improve the referral in-
take process would perhaps be to better align risk of CKD
progression with resource utilization, which in turn may
lead to a prospect for larger gains in improving the quality
of care.
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